{
  "id": "5a774585faa1ab7d2e000005",
  "type": "summary",
  "question": "What is masitinib an inhibitor of?",
  "ideal_answer": "Masitinib is an inhibitor of mast cell-glia axis and a Fyn kinase blocker.  It is an oral tyrosine kinase inhibitor with activity against c-Kit and platelet-derived growth factor receptors (PDGFR).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/25961655",
    "http://www.ncbi.nlm.nih.gov/pubmed/25344204",
    "http://www.ncbi.nlm.nih.gov/pubmed/24602916"
  ],
  "snippets": [
    {
      "text": "This study evaluated the therapeutic potential of masitinib, an oral tyrosine kinase inhibitor with activity against c-Kit and platelet-derived growth factor receptors (PDGFR), to reduce ischemic brain area and neurological deficit. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25344204",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Masitinib, a selective tyrosine kinase inhibitor, was investigated as a radiosensitizer in three primary feline injection-site sarcoma (ISS) cell lines. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24602916",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Dual actions of masitinib as an inhibitor of mast cell-glia axis and a Fyn kinase blocker are discussed in the context of AD pathology.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25961655",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}